rash from semaglutide shot Hypersensitivity to glucagon‐like peptide‐1 receptor agonists: A case of delayed urticaria‐like to dulaglutide and literature review - Bianchi - 2024 - JEADV Clinical Practice TrimRX | Semaglutide Injection Site

In one study, patients regained about two-thirds of the weight they had lost just one year after stopping semaglutide treatment, and their cardiometabolic risk markers (blood sugar, cholesterol, etc.) reverted toward baseline (source)

This discussion should begin with clarifying treatment goals and expectations specifically defining what "results" means in measurable terms

One 10 mL bottle covers three vials with margin

Patients experiencing new or worsening skin symptoms should report these to their healthcare provider for appropriate evaluation, as distinguishing between benign reactions and potentially serious hypersensitivity is essential for safe continuation of therapy

Compounded products are regulated at the state level